Drug Profile
Selepressin - Ferring Pharmaceuticals
Alternative Names: FE-202158Latest Information Update: 02 Mar 2021
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class Peptides; Vasoconstrictors; Vasopressins
- Mechanism of Action Vasopressin 1a receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 02 Mar 2021 Discontinued - Phase-II for Septic shock in Canada (IV)
- 02 Mar 2021 Discontinued - Phase-II/III for Septic shock in Belgium, Denmark, France, Netherlands, USA (IV)
- 01 Jul 2015 Phase-II/III clinical trials in Septic shock in Netherlands, USA (IV) (EudraCT2014-003973-41)